Deliconstantinos G, Villiotou V, Stavrides J C
Department of Experimental Physiology, University of Athens Medical School, Greece.
Biochem Pharmacol. 1995 May 26;49(11):1589-600. doi: 10.1016/0006-2952(95)00094-g.
Endothelium-derived relaxing factor/nitric oxide (EDRF/NO) is produced by the vascular wall and is a key modulator of vascular tone and blood pressure. Since reduced EDRF/NO release from the endothelium is a major key event in the development of atherosclerosis, we investigated the effect of cholesterol on endothelial cell particulate (membrane-bound) NO synthase activity. Low concentrations (up to 0.2 mM) of liposomal cholesterol progressively activated plasma membrane-bound NO synthase. Increasing cholesterol concentration above that which maximally stimulated enzyme activity produced a progressive inhibition with respect to the control value. In time course experiments using endothelial cell plasma membranes enriched with cholesterol, changes in NO production were followed by analogous changes in soluble guanylate cyclase activity (sGC). N-Monomethyl-L-arginine (L-NMMA) (1 mM) inhibited particulate NO synthase activity at all cholesterol concentrations used with subsequent decreases in cGMP production. Egg lecithin liposomes (free of cholesterol) had no effect on NO synthase activity. A three-fold increase in superoxide (O2-) and a 2.5-fold increase in NO formation followed by an eight-fold increase in peroxynitrite (ONOO-) production by cholesterol-treated microsomes isolated from endothelial cells was observed, one which rose further up to eight-fold in the presence of superoxide dismutase (SOD) (10 U/mL). Cholesterol had no effect on Lubrol-PX solubilized membrane-bound NO synthase or on cytosolic (soluble) NO synthase activities of endothelial cells. Cholesterol modulated lipid fluidity of plasma membranes labelled with 1,6-diphenyl-1,3,5-hexatriene (DPH) as indicated by the steady state fluorescence anisotropy [(ro/r)-1]-1. Arrhenius plots of [(ro/r)-1]-1 indicated that the lipid phase separation of the membranes at 26.2 +/- 1.5 degrees was elevated to 34.4 +/- 1.9 degrees in cholesterol-enriched membranes, consistent with a general decrease in membrane fluidity. Cholesterol-enriched plasma membranes treated with egg lecithin liposomes showed a lipid phase separation at 27.5 +/- 1.6 degrees, indicating the reversible effect of cholesterol on membrane lipid fluidity. Arrhenius plots of NO synthase activity exhibited break point at 26.9 +/- 1.8 degrees which rose to 35.6 +/- 2.1 degrees in 0.5 mM cholesterol-treated plasma membranes and decreased to 21.5 +/- 1.4 degrees in plasma membranes treated with 0.2 mM cholesterol. The allosteric properties of plasma membrane-bound NO synthase inhibited by Mn2+ (as reflected by changes in the Hill coefficient) were changed by cholesterol, consistent with modulations of the fluidity of the lipid microenvironment of the enzyme.(ABSTRACT TRUNCATED AT 400 WORDS)
内皮源性舒张因子/一氧化氮(EDRF/NO)由血管壁产生,是血管张力和血压的关键调节因子。由于内皮细胞释放的EDRF/NO减少是动脉粥样硬化发生发展的一个主要关键事件,我们研究了胆固醇对内皮细胞微粒体(膜结合)一氧化氮合酶活性的影响。低浓度(高达0.2 mM)的脂质体胆固醇可逐渐激活质膜结合的一氧化氮合酶。当胆固醇浓度超过最大刺激酶活性的浓度时,相对于对照值会产生逐渐的抑制作用。在使用富含胆固醇的内皮细胞质膜进行的时间进程实验中,一氧化氮产生的变化伴随着可溶性鸟苷酸环化酶活性(sGC)的类似变化。N-单甲基-L-精氨酸(L-NMMA)(1 mM)在所有使用的胆固醇浓度下均抑制微粒体一氧化氮合酶活性,随后cGMP生成减少。卵磷脂脂质体(不含胆固醇)对一氧化氮合酶活性无影响。观察到从内皮细胞分离的经胆固醇处理的微粒体中超氧化物(O2-)增加了三倍,一氧化氮生成增加了2.5倍,随后过氧亚硝酸盐(ONOO-)生成增加了八倍,在超氧化物歧化酶(SOD)(10 U/mL)存在下,过氧亚硝酸盐生成进一步增加至八倍。胆固醇对Lubrol-PX溶解的膜结合一氧化氮合酶或内皮细胞的胞质(可溶性)一氧化氮合酶活性无影响。胆固醇调节了用1,6-二苯基-1,3,5-己三烯(DPH)标记的质膜的脂质流动性,这通过稳态荧光各向异性[(ro/r)-1]-1来表示。[(ro/r)-1]-1的阿伦尼乌斯图表明,在26.2±1.5℃时膜的脂质相分离在富含胆固醇的膜中升高到34.4±1.9℃,这与膜流动性的普遍降低一致。用卵磷脂脂质体处理的富含胆固醇的质膜在27.5±1.6℃时出现脂质相分离,表明胆固醇对膜脂质流动性具有可逆作用。一氧化氮合酶活性的阿伦尼乌斯图在26.9±1.8℃出现转折点,在0.5 mM胆固醇处理的质膜中升至35.6±2.1℃,在0.2 mM胆固醇处理的质膜中降至21.5±1.4℃。胆固醇改变了被Mn2+抑制的质膜结合一氧化氮合酶的变构性质(如通过希尔系数的变化所反映),这与酶脂质微环境流动性的调节一致。(摘要截短至400字)